Pravastatin sodium |
| Catalog No.GC14538 |
A potent HMG-CoA reductase inhibitor
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 81131-70-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Pravastatin sodium is a high selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase of 44.1nM [1].
Pravastatin is a competitive inhibitor of HMG-CoA reductase. It has shown to reduce the level of plasma LDL both in animals and humans through inhibiting cellular cholesterol synthesis. Pravastatin was reported to reduce cellular cholesterol synthesis in three types of macrophages including J-774 A.1 macrophage-like cell line, human monocyte derived macrophages (HMDM) and mouse peritoneal macrophages (MPM) with IC50 values of 0.08, 6.3 and 7.8μg/ml, respectively [2].
Besides the benefit in cardiovascular disease prevention, pravastatin also has efficacy of preventing tumor growth in some degree. However, it has shown that the normal hepatocytes are more sensitive to pravastatin than the tumor cells since pravastatin is selectively taken up by OATP1B1 which is exclusively expressed in normal hepatocytes [3].
References:
[1] Bolego C, Poli A, Cignarella A, Catapano AL, Paoletti R. Novel statins: pharmacological and clinical results. Cardiovasc Drugs Ther. 2002 May;16(3):251-7.
[2] Keidar S, Aviram M, Maor I, Oiknine J, Brook JG. Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies. Br J Clin Pharmacol. 1994 Dec;38(6):513-9.
[3] Menter DG, Ramsauer VP, Harirforoosh S, Chakraborty K, Yang P, Hsi L, Newman RA, Krishnan K. Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. PLoS One. 2011;6(12):e28813.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *